365 related articles for article (PubMed ID: 25060761)
21. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
22. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
23. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
Kishore L; Kaur N; Singh R
Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
[TBL] [Abstract][Full Text] [Related]
24. Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy.
Abe H; Sakurai A; Ono H; Hayashi S; Yoshimoto S; Ochi A; Ueda S; Nishimura K; Shibata E; Tamaki M; Kishi F; Kishi S; Murakami T; Nagai K; Doi T
J Med Invest; 2018; 65(3.4):208-215. PubMed ID: 30282862
[TBL] [Abstract][Full Text] [Related]
25. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
26. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
27. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
28. Novel urinary biomarkers in early diabetic kidney disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Curr Diab Rep; 2014 Aug; 14(8):513. PubMed ID: 24919751
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of diabetic nephropathy, the present and the future.
Jim B; Santos J; Spath F; Cijiang He J
Curr Diabetes Rev; 2012 Sep; 8(5):317-28. PubMed ID: 22698077
[TBL] [Abstract][Full Text] [Related]
30. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
[TBL] [Abstract][Full Text] [Related]
31. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
32. Novel urinary biomarkers in pre-diabetic nephropathy.
Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
[TBL] [Abstract][Full Text] [Related]
33. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice.
Mohamed R; Ranganathan P; Jayakumar C; Nauta FL; Gansevoort RT; Weintraub NL; Brands M; Ramesh G
J Mol Med (Berl); 2014 Dec; 92(12):1245-56. PubMed ID: 25249008
[TBL] [Abstract][Full Text] [Related]
34. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
[TBL] [Abstract][Full Text] [Related]
36. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
37. Urinary exosomes: Potential biomarkers for diabetic nephropathy.
Sinha N; Kumar V; Puri V; Nada R; Rastogi A; Jha V; Puri S
Nephrology (Carlton); 2020 Dec; 25(12):881-887. PubMed ID: 32323449
[TBL] [Abstract][Full Text] [Related]
38. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
39. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
Satirapoj B; Pooluea P; Nata N; Supasyndh O
J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
[TBL] [Abstract][Full Text] [Related]
40. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy.
Sakurai A; Ono H; Ochi A; Matsuura M; Yoshimoto S; Kishi S; Murakami T; Tominaga T; Nagai K; Abe H; Doi T
PLoS One; 2019; 14(5):e0216788. PubMed ID: 31150422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
